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Behavioral/Cognitive

Stress-Induced Reinstatement of Nicotine Preference
Requires Dynorphin/Kappa Opioid Activity in the
Basolateral Amygdala
X Stephanie K. Nygard,1,2 Nicholas J. Hourguettes,1 X Gabe G. Sobczak,1 William A. Carlezon,5
and X Michael R. Bruchas1,3,4
1Department of Anesthesiology, 2Department of Psychiatry, 3Washington University Pain Center, and 4Department of Neuroscience, Washington
University School of Medicine, St. Louis, Missouri 63110; and 5Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont,
Massachusetts 02478

The dynorphin (DYN)/kappa-opioid receptor (KOR) system plays a conserved role in stress-induced reinstatement of drug seeking for
prototypical substances of abuse. Due to nicotine’s high propensity for stress-induced relapse, we hypothesized that stress would induce
reinstatement of nicotine seeking-like behavior in a KOR-dependent manner. Using a conditioned place preference (CPP) reinstatement
procedure in mice, we show that both foot-shock stress and the pharmacological stressor yohimbine (2 mg/kg, i.p.) induce reinstatement
of nicotine CPP in a norbinaltorphimine (norBNI, a KOR antagonist)-sensitive manner, indicating that KOR activity is necessary for
stress-induced nicotine CPP reinstatement. After reinstatement testing, we visualized robust c-fos expression in the basolateral amygdala
(BLA), which was reduced in mice pretreated with norBNI. We then used several distinct but complementary approaches of locally
disrupting BLA KOR activity to assess the role of KORs and KOR-coupled intracellular signaling cascades on reinstatement of nicotine
CPP. norBNI injected locally into the BLA prevented yohimbine-induced nicotine CPP reinstatement without affecting CPP acquisition.
Similarly, selective deletion of BLA KORs in KOR conditional knock-out mice prevented foot-shock-induced CPP reinstatement. Together, these findings strongly implicate BLA KORs in stress-induced nicotine seeking-like behavior. In addition, we found that chemogenetic activation of G␣i signaling within CaMKII␣ BLA neurons was sufficient to induce nicotine CPP reinstatement, identifying an
anatomically specific intracellular mechanism by which stress leads to reinstatement. Considered together, our findings suggest that
activation of the DYN/KOR system and G␣i signaling within the BLA is both necessary and sufficient to produce reinstatement of nicotine
preference.
Key words: basolateral amygdala; conditioned place preference; kappa opioid receptors; nicotine; reinstatement; stress

Significance Statement
Considering the major impact of nicotine use on human health, understanding the mechanisms by which stress triggers reinstatement of drug-seeking behaviors is particularly pertinent to nicotine. The dynorphin (DYN)/kappa-opioid receptor (KOR) system
has been implicated in stress-induced reinstatement of drug seeking for other commonly abused drugs. However, the specific role,
brain region, and mechanisms that this system plays in reinstatement of nicotine seeking has not been characterized. Here, we
report region-specific engagement of the DYN/KOR system and subsequent activation of inhibitory (Gi-linked) intracellular
signaling pathways within the basolateral amygdala during stress-induced reinstatement of nicotine preference. We show that the
DYN/KOR system is necessary to produce this behavioral state. This work may provide novel insight for the development of
therapeutic approaches to prevent stress-related nicotine relapse.

Nicotine use is the leading cause of preventable death, being responsible for about one in every five deaths in the United States,
and has strikingly high rates of relapse (Lerman et al., 2014).

Relapse to smoking occurs in ⬎90% of abstinent smokers and
stress is the most common reason reported for relapse (al’Absi et
al., 2007). In laboratory studies, both foot shock and the pharmacological stressor yohimbine have been shown to reinstate drug-
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seeking behaviors reliably for prototypical substances of abuse
such as cocaine, opiates, and nicotine (Sinha et al., 2011; Mantsch
et al., 2016). Yohimbine is an ␣-2 adrenergic receptor antagonist
that produces responses of stress and dysphoria in humans and
rodents and there is accumulating evidence that the dynorphin
(DYN)/kappa-opioid receptor (KOR) system plays a role in these
effects (Koob, 2013; Grella et al., 2014; Lalanne et al., 2014; Zhou
and Leri, 2016). Conditioned place preference (CPP) procedures
are especially useful to study nicotine reinstatement due to the
importance of contextual cues in the nicotine addiction process
(Subramaniyan and Dani, 2015) and because cue-induced craving is a strong predictor of relapse to nicotine use in humans
(Droungas et al., 1995; Janes et al., 2010). In addition, place preference procedures are increasingly being used in human drug
abuse studies, providing more validity for CPP rodent models
(Napier et al., 2013; Astur et al., 2016). Redila and Chavkin
(2008), show that stress-induced reinstatement of cocaine CPP is
blocked by the KOR antagonist norbinaltorphimine (norBNI).
Forced swim stress has been shown to reinstate nicotine CPP in
mice (Jackson et al., 2013; Titomanlio et al., 2014) and can be
prevented by KOR antagonism (Jackson et al., 2013), suggesting
that KOR activation through endogenous DYN released during
stress is necessary for reinstatement. We recently showed that
activating the KOR system with a KOR agonist is sufficient to
induce reinstatement of both cocaine and nicotine CPP (AlHasani et al., 2013a; Al-Hasani et al., 2013b). However, how the
KOR system plays a role in nicotine reinstatement is less understood. Here, we tested the hypothesis that foot-shock stress and
the pharmacological stressor yohimbine would both produce endogenous DYN release and activate specific regional KORs and
induce reinstatement of nicotine CPP.
The amygdala is known to be involved in reward-context/cue
associations, specifically functioning to assign importance to reward associated cues and to continually update the value of those
cues (Murray, 2007; Koob, 2009). The basolateral amygdala
(BLA) is KOR rich (Mansour et al., 1988) and activation of DYN/
KOR systems in the BLA has anxiogenic effects (Bruchas et al.,
2009; Knoll et al., 2011; Crowley et al., 2016). KOR function in the
BLA and associated circuits is activated by stress and plays a role
in stress-induced dysphoria (Land et al., 2008). Nicotine CPP has
been shown to be potentiated by stress via the BLA without affecting other anxiety-related behaviors (Smith et al., 2012).
Activation of KORs with the KOR agonist U50-488 decreases
synaptic transmission and LTP in the BLA and inhibits glutamatergic activity of BLA to bed nucleus of stria terminalis (BNST)
projection neurons to mediate anxiogenic behavior (Huge et al.,
2009; Crowley et al., 2016). Considering the effects of BLA KOR
activation on anxiety-like behavior and on cellular activity within
the BLA, we hypothesized that KOR signaling in the BLA may
play a role in stress-induced nicotine CPP reinstatement. Specifically, we hypothesized that stress-induced activation of the endogenous DYN/KOR system within the BLA would be necessary
for stress to reinstate nicotine CPP.
Here, we report that DYN/KOR activity in the BLA is a key
mediator of stress-induced nicotine reinstatement. We show that
activation of G␣i signaling within the BLA is sufficient for nico-

tine CPP reinstatement and that BLA KORs are necessary for this
effect. Our results provide new insights on how KORs transduce
the effects of stress and add to the scientific basis for considering
KOR antagonists as potential therapies for nicotine use disorders.

Materials and Methods
Animals

Male WT C57BL/6 mice, KOR ⫺/⫺, DYN ⫺/⫺, KOR conditional KO
(cKO) (Van’t Veer et al., 2013a), and KOR cKO tdTomato (a line generated
by crossing KOR cKO mice with Ai9tdTomato reporter mice) mice with
a C57BL6 background weighing 25–30 g (8 –10 weeks old) at the time of
behavioral testing were used. Surgery was performed on 6- to 7-week-old
mice to ensure appropriate age at time of CPP testing. Mice were housed
3–5 per cage and maintained in a holding room adjacent to the behavioral testing room for at least 7 d before the start of testing. Mice had ad
libitum access to food and water and were maintained on a 12 h light/dark
schedule (lights on at 7:00 A.M. and off at 7:00 P.M.). All procedures were
approved by the Animal Care and Use Committee of Washington
University and were in accordance with National Institutes of Health
guidelines.

Genotyping
Three- to 4-week-old mice were tail clipped to obtain DNA samples for
genotyping. PCR screening was used with the following primers: KOR ⫺/⫺
(5⬘-GTC TAA TTG TCT TTT GGC CAC TGC AGA TGG-3⬘ and: 3⬘-TAG
ATG TTG GTT GCG GTC TTC ATC TTC GTG-5⬘) yield a 450 bp product
in WT mice and (5⬘-TGC TCC TGC CGA GAA AGT ATC CAT CAT
GGC-3⬘ and 3⬘-CGC CAA GCT CTT CAG CAA TAT CAC GGG TAG-5⬘)
which yields a 380 PCR product in KO mice. The following primers were
used to genotype DYN ⫺/⫺ mice: 5⬘-DYN (Mouse) 30 bp: ATC CTT TCA
GAT TTG CTC CCT GGA GTG CCA; 3⬘-DYN (Mouse) 30 bp: CAT AGC
GCT TCT GGT TGT CCC ACT TCA GCT (500 bp PCR product); 5⬘ Neo
(MGC) 380 30 bp: TGC TCC TGC CGA GAA AGT ATC CAT CAT GGC; 3⬘
Neo (MGC) 380 30 bp: CGC CAA GCT CTT CAG CAA TAT CAC GGG
TAG (380 bp PCR product). KOR cKO mice: (5⬘-TATTGCTGAC
CTATCGTGAAC-3⬘, 5⬘-GAGCTACTGTTTTCATACCATTTA-3⬘, and 5⬘TTGAGGCTACTAGTTTCCAAAG-3⬘), with PCR products of 399 bp for
WT DNA, 459 bp for unrecombined DNA, and 563 bp for the knock-out
(Van’t Veer et al., 2013a). Ai9 was confirmed with the following primers: Ai9
WT FWD (oIMR9020) 20 bp: AAG GGA GCT GCA GTG GAG TA; Ai9 WT
REV (oIMR9021) 20 bp: CCG AAA ATC TGT GGG AAG TC; Ai9 Mutant
FWD (oIMR9105) 19 bp: CTG TTC CTG TAC GGC ATG G; Ai9 Mutant
REV (oIMR9103) 20 bp: GGC ATT AAA GCA GCG TAT CC. with PCR
products of 275 bp for WT and 150 bp for tdTomato positive.

Drug administration
(⫺)-Nicotine hydrogen tartrate salt (Sigma-Aldrich, N5260) (0.5 mg/kg,
corrected for the weight of the tartrate salt) was dissolved in saline and
injected subcutaneously. Yohimbine hydrochloride (2 mg/kg) (SigmaAldrich, Y3125) was dissolved in sterile water and injected intraperitoneally.
Norbinaltorphimine (norBNI) dihydrochloride (log no. 13335– 66A) was
injected intraperitoneally (10 mg/kg) or intracranially (2.5 g/1 l), dissolved in saline or ACSF, respectively, as the vehicle. Clozapine N-oxide
(CNO, 1 mg/kg, i.p.) was purchased from Enzo Life Sciences, BML-N51050025). CNO was made in 0.5% DMSO in saline.

Handling/habituation
Mice were transported to the CPP behavior testing room and handled
once per day for at least 7 d before behavioral testing. Each mouse was
scruffed, its belly rubbed, and head gently poked to habituate them to
subcutaneous injections. Prior handling is important in inducing nicotine CPP in mice (Grabus et al., 2006).

CPP
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We used a modified three-chamber CPP apparatus consisting of two
square boxes (27 cm ⫻ 27 cm) that served as the conditioning chambers
separated by a small center area that served as the passage way (5 cm
wide ⫻ 8 cm long) between boxes, as described previously (Land et al.,
2008; Bruchas et al., 2011; Al-Hasani et al., 2013a; Al-Hasani et al.,
2013b). Boxes had 2.5 cm black-and-white vertical stripes or horizontal
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Table 1. Average time spent in drug-paired side during each test for all groups
Time (s)
Experiment

Pre

Post

Extinction

Reinstate

Prime

Saline-only (foot shock)
Foot shock ⫹ saline
Foot shock ⫹ norBNI
Saline-only (yohimbine)
Yohimbine ⫹ saline
Yohimbine ⫹ norBNI
WT
KOR ⫺/⫺ ⫹ yohimbine
DYN ⫺/⫺ ⫹ yohimbine
mCitrine
Gi
BLA ACSF ⫹ yohimbine
BLA norBNI ⫹ yohimbine
KORcKO/BLA/GFP/foot shock
KORcKO BLA/Cre/foot shock

471.1 (11.79)
449.2 (10.30)
438.2 (19.10)
548.2 (65.21)
407.6 (18.33)
417.2 (23.49)
461.0 (27.46)
482.0 (15.34)
396.4 (21.32)
445.8 (49.5)
461.5 (8.76)
423.5 (24.42)
451.9 (14.76)
450.2 (20.22)
458.8 (17.84)

482.6 (27.90)
596.8 (19.51)
586.2 (21.76)
441.4 (56.13)
573.4 (24.71)
594.8 (19.04)
558.2 (47.76)
594.7 (12.51)
541.5 (41.63)
613.0 (50.92)
611.8 (36.37)
581.2 (26.21)
568.2 (13.60)
541.8 (20.76)
576.9 (17.52)

518.7 (27.89)
466.1 (17.79)
480.9 (20.73)
505.9 (52.09)
489.9 (25.14)
524.1 (24.27)
382.4 (33.40)
470.4 (40.52)
431.8 (31.89)
585.1 (65.44)
564.2 (28.55)
487.4 (29.00)
433.8 (24.86)
512.3 (27.74)
509.4 (26.98)

523.7 (20.34)
600.6 (26.96)
471.7 (21.02)
532.3 (51.26)
688.9 (47.47)
530.1 (32.79)
520.1 (38.20)
497.3 (32.82)
443.6 (33.48)
547.9 (67.88)
684.3 (59.74)
614.8 (27.59)
487.2 (54.88)
653.9 (49.18)
511.1 (32.54)

489.4 (36.57)
637.1 (73.91)
579.2 (93.22)
N/A
N/A
N/A
784.8 (16.41)
825.5 (62.42)
590.0 (83.81)
N/A
N/A
610.6 (104.1)
531.5 (63.85)
738.5 (82.66)
670.4 (63.18)

Shown are the mean time (SEM) in seconds spent in the drug paired side of the CPP apparatus during each stage of behavioral testing (pre, post, extinction, reinstate, prime) for each group in each experiment in the study.
N/A, Not applicable.

stripes and floors were covered with 500 ml of bedding on each side. The
floor of the center area was smooth Plexiglas.
Mice were transported to the CPP behavior testing room and handled
once per day for at least 7 d before behavioral testing. Mice were then
conditioned using a semibiased and counterbalanced CPP/reinstatement
protocol adapted from previous studies (Brielmaier et al., 2008; AlHasani et al., 2013a; Al-Hasani et al., 2013b; Ngolab et al., 2015). On day
one, mice were pretested for an initial bias to the conditioning apparatus
and allowed to explore all three regions of the box drug-free for 20 min.
Mice that spent ⬎150 s in one side of the apparatus (⬃10 –15%) were
nicotine paired with the least preferred side. Remaining mice were paired
in a counterbalanced fashion. Mice that spent ⬎300 s on one side during
the pretest were excluded due to potential side bias. However, overall,
our chambers do not appear to be biased, with mice (n ⫽ 73) spending an
average of 510.80 s (SEM 30.15) in the horizontal side and 487.50 s (SEM
35.02) in the vertical side before conditioning, with no statistically significant difference between the groups. Conditioning occurred over the
following 2 d in which mice received a subcutaneous injection of saline in
the morning and immediately confined to one side of the CPP box for 20
min. In the afternoon, at least 4 h after the morning conditioning session,
mice received an injection of nicotine (0.5 mg/kg, s.c.) and were immediately confined to the opposite side for 20 min This dose of nicotine has
been optimized for CPP in our laboratory (Al-Hasani et al., 2013a; AlHasani et al., 2013b) and has been shown to be effective in inducing CPP
in mice (Grabus et al., 2006b; Matta et al., 2007; Jackson et al., 2013).
Control (vehicle-injected) mice received saline injections during both
A.M. and P.M. conditioning sessions. The following day, mice were
tested for a preference for the nicotine-paired side following the same
procedure as the pretest. Preference scores were calculated by subtracting
time spent in the drug-paired side during the pretest from time spent in
the drug-paired side during the posttest. Mice were considered conditioned if their CPP score was ⱖ10% of their total conditioning time
during the posttest.

Extinction and reinstatement
As described previously for prototypical drugs of abuse (Al-Hasani et al.,
2013a; Al-Hasani et al., 2013b; Portugal et al., 2014), we used a modified
extinction procedure in which mice that expressed a CPP for the nicotine
side were then extinguished for 2 d following the same procedure as the
conditioning sessions, but instead of nicotine in the P.M. sessions, mice
received saline injections in both A.M. and P.M. conditioning sessions.
Extinction scores were calculated by subtracting the time spent in the
drug-paired side during the posttest from time spent in the drug-paired
side during the extinction test (Table 1). Mice with extinction scores that
were ⬍10% of total conditioning time were considered to be extinguished (95% of those tested) and were then tested for reinstatement
with either yohimbine (2 mg/kg, i.p) 5 min before reinstatement testing

(as reported in Mantsch et al., 2010) or intermittent, unavoidable footshock stress for 15 min, which was reported previously to engage the
KOR system (Redila and Chavkin, 2008). For systemic norBNI experiments, mice were initially split into two groups. One group was conditioned with nicotine and another group was treated with saline during
both A.M. and P.M. conditioning sessions to serve as non-drug-treated
controls. After initial CPP testing, nicotine-conditioned mice were split
into two groups with equal preference scores (yohimbine or foot shock ⫹
saline and yohimbine or foot shock ⫹ norBNI). After the extinction test
and the morning of the reinstatement test (18 and 4 h before reinstatement), mice received an injection of saline or norBNI (10 mg/kg, i.p.)
depending on group, as described previously (two injections of norBNI
or saline) (McLaughlin et al., 2003; Bruchas et al., 2007; Land et al., 2008;
Smith et al., 2012; Melief et al., 2011).
For yohimbine reinstatement, yohimbine (2 mg/kg) was injected intraperitoneally and mice were placed back in their home cages. Control
(vehicle) mice were injected with saline and placed back in their home
cage. After 5 min, mice were placed in the center of the CPP apparatus
and tested for reinstatement as described previously (Land et al., 2008;
Mantsch et al., 2010; Bruchas et al., 2011; Jackson et al., 2013). For footshock stress reinstatement, 20 min before reinstatement testing, mice
were shuttled from the CPP testing room to an intentionally different
adjacent room with the shock apparatus (Med Associates, MED-PC,
RRID:SCR_012156), put in the shock box for 5 min of habituation, and
then were exposed to 15 min of random shocks (0.8 mA) that lasted 0.5 s
each with an intershock interval ranging from 10 to 70 s with a mean of
40 s. Vehicle-treated controls were put in shock apparatus for 20 min
before reinstatement testing, but did not receive shocks. Mice were then
shuttled back to the CPP testing room and immediately tested for nicotine CPP reinstatement. Our shock protocol has been shown to reinstate
cocaine–CPP in mice (Song et al., 2007; Redila and Chavkin, 2008) and
nicotine self-administration in rats (Buczek et al., 1999). For DREADD
experiments, CNO (1 mg/kg) was injected intraperitoneally and mice
were placed back in their home cages for 30 min before being placed into
CPP apparatus for reinstatement testing. Given the timing effects of KOR
agonist on potentiation and reinstatement, this time point was chosen to
produce a maximally robust effect (McLaughlin et al., 2003; Smith et al.,
2012; Al-Hasani et al., 2013a; Al-Hasani et al., 2013b).

Stereotaxic microinjections
Local pharmacology. For local KOR antagonist experiments, mice were
injected bilaterally (BLA coordinates ML ⫾ 3.1, AP ⫺1.8, DV ⫺5; Bruchas et al., 2009; Smith et al., 2012) with the KOR antagonist norBNI (2.5
g/1 l) or vehicle (ACSF) (see Fig. 4 A, B). The injection volume was 500
nl/side and was injected at a rate of 100 nl/min. The syringe was left in
place for 10 min after the injection to allow for drug diffusion. Due to the
long-lasting properties of the KOR antagonist norBNI (Bruchas et al.,

Nygard et al. • Stress-Induced Nicotine Reinstatement Requires BLA KORs

9940 • J. Neurosci., September 21, 2016 • 36(38):9937–9948

2007), we were able to give mice 7 d to recover before the start of behavioral testing.
Viral injections. For KOR conditional KO studies, KOR floxed (KOR
cKO; see Fig. 5A, left) mice were bilaterally injected into the BLA with
either AAV5-Cre-GFP (8.1 ⫻ 10 12 vg/ml) or the control virus AAV5GFP, both purchased from UNC Viral Vector Core (see Fig. 5D–F ).
Then, 400 nl of virus was injected on each side at a rate of 100 nl/min. The
syringe was left in place for an additional 8 min before retracting to avoid
capillary effects, for a total injection time of 12 min per side. To confirm
conditional deletion of KORs from KOR cKO mice and to visualize
successful cre recombination, KOR cKO mice were also crossed with the
cre-dependent Ai9 tdTomato reporter mouse line (Madisen et al., 2010),
resulting in a new KOR cKO tdTomato mouse line. When KOR cKO tdTomato
mice are injected with AAV-cre-GFP, KOR is conditionally deleted and tdTomato/GFP are simultaneously expressed in infected cells (see Fig. 5A–C)
to confirm robust, virally induced cre recombinase activity.
For DREADD experiments, AAV5-CaMKII␣-HA-hM4D(Gi)-IRESmCitrine (2.7 ⫻ 10 12 VM/ml) or AAV5-CaMKII␣-mCitrine (control
virus), purchased from UNC Vector Core was injected bilaterally into the
BLA (BLA coordinates ML ⫾ 3.1, AP ⫺1.8, DV ⫺5) at a volume of 300 nl
over 3 min per side. The syringe was left in place for 10 min total to allow
for viral diffusion. Mice were given 3 weeks for viral expression before
behavioral testing (see Fig. 6A–C).

Immunohistochemistry
Mice were transcardially perfused with ice-cold 4% paraformaldehyde 90
min after yohimbine-induced reinstatement and tissue was stained to
visualize c-fos expression. Mice that had surgery before testing were perfused to confirm viral expression in the BLA (see Figs. 5E,F; 6A–C). Mice
with no reporter gene expression on both sides of the brain or misplaced
expression were excluded from behavioral analysis.
After perfusion, brains were stored in 30% sucrose solution until sectioning (30 m) and staining. Briefly, as described previously (Al-Hasani
et al., 2013b; McCall et al., 2015), for c-fos IHC, sections (6 – 8 sections
per well, 2 ml volume for all washes and incubations) were washed 3
times in PBS and then blocked with blocking buffer (PBS with 5% normal goat serum and 0.3% Triton X-100) for 1 h at room temperature.
Sections were then incubated overnight at 4°C in blocking buffer containing the primary antibody for c-fos (c-fos rabbit polyclonal IgG; Santa
Cruz Biotechnology, sc-52 RRID:AB_2106783,1:500). After 24 h of primary antibody incubation, sections were washed 3 times in PBS before
secondary antibody incubation (Alexa Fluor 594 goat-anti-rabbit IgG;
Thermo Fisher Scientific, R37117 RRID:AB_2556545, 1:1000) for 2 h at
room temperature. Sections were then washed 3 more times in PBS and
2 times in PB before Nissl staining (Neurotrace 435/455 Blue Fluorescent
Nissl stain; ZcomThermo Fisher Scientific, N21479). Sections were incubated for 1 h in 2 ml PBS with 5 l of Neurotrace and then washed 3 more
times in PBS and 3 more times in PB. Tissues from mice that were
perfused just to confirm viral expression were not stained for c-fos, so
staining began with the Neurotrace step. Free-floating sections were
mounted in 0.1 PB and coverslips were applied over mounted sections
with Vectashield Hard Set mounting medium (Vector Laboratories,
H-1400 RRID:AB_2336787). Slides were imaged on both epifluorescent
and confocal microscopes. For quantification, images were acquired
with the same gain and exposure time across brain regions and treatment
groups.

Cell quantification

C-fos ⫹ cells were quantified as described previously (Al-Hasani et al.,
2013b; Kim et al., 2013; McCall et al., 2015). Briefly, images from 3
consecutive sections from n ⫽ 6 mice per group were taken on a epifluorescent microscope. Images were broken down into individual channels
(Neurotrace: blue channel; c-fos: red channel) and analyzed separately.
ImageJ (RRID:SCR_003070) particle analysis was used to count the
number of c-fos-positive cells relative to the number of Neurotracepositive cells within a given region. Images were overlaid and the percentage of colabeled cells was reported. Counting was performed blinded
to treatment. The percentage of Ai9 tdTomato and GFP coexpression in
the BLAs of KORcKO tdTomato mice injected with AAV5-cre-GFP was

done the same way; however, the individual channels were different
(Neurotrace: blue channel-not shown; GFP: green channel; and
TdTomato: red channel). The percentage of GFP/TdTomato-colabled
cells is presented as the percentage of Neurotrace-positive cells within a
given region.

Data analysis and statistics
Two-way (on time/stage) repeated-measures (RM)-ANOVAs were
used to compare differences in preference scores and locomotor responses (separately) between groups during each stage of testing. In
cases in which groups were unequal for each stage of testing (because
groups were split to move on to nicotine-prime reinstatement testing
or perfused after reinstatement testing), prime data were analyzed
separately with one-way RM-ANOVA or paired t test as appropriate.
One-way ANOVAs were used to analyze c-fos quantification data.
Significant ANOVAs were followed by Bonferonni post hoc comparisons and statistically significant differences were determined at p ⬍
0.05. All data and statistical analysis was performed using Prism version 6 or 7 (GraphPad, RRID:SCR_002798).

Results
KOR activation is necessary for foot-shock stress-induced
nicotine reinstatement
To determine whether stress would reinstate a previously extinguished CPP for nicotine, we exposed mice to 15 min of unavoidable
intermittent foot shock before reinstatement testing (see Fig. 1A for
experimental timeline and foot-shock protocol). We found that foot
shock reliably reinstated nicotine CPP and that this effect is blocked
by pretreatment with norBNI (10 mg/kg, i.p; n ⫽ 12–16 per group,
two-way RM-ANOVA, F(2,40) ⫽ 16.84, p ⬍ 0.001; Fig. 1C). Post hoc
comparisons showed a significant increase in reinstatement scores in
the foot shock ⫹ saline group compared with saline-only controls
and stressed mice pretreated with norBNI (all comparisons p ⬍
0.001; see Table 1 for comparison of time spent in the drug-paired
side during each stage of testing). Furthermore, norBNI did not have
an effect on nicotine-primed reinstatement in nicotine-conditioned
mice (n ⫽ 6 –9 per group, one-way ANOVA, F(2,18) ⫽ 9.25, p ⫽
0.002), consistent with previous reports (Schindler et al., 2010; Jackson et al., 2013). Post hoc comparisons showed that a nicotine prime
injection reinstated nicotine conditioned mice regardless of norBNI
pretreatment (saline-only compared with foot shock ⫹ saline, p ⫽
0.002; saline-only compared with foot shock ⫹ norBNI, p ⫽ 0.037;
Fig. 1C). As expected, nicotine decreased locomotor behavior during
conditioning sessions in both groups of nicotine-conditioned mice
compared with saline-treated controls (n ⫽ 12–16 per group, twoway RM-ANOVA, F(2,40) ⫽ 11.29, p ⬍ 0.001; Fig. 1D). No differences were seen in locomotor behavior during drug-free testing (see
Fig. 1A,B for timeline and representative tracks of distance traveled
during each testing time point). However, during the nicotine prime
test, nicotine treatment again decreased locomotor responses compared with saline controls only in mice from the foot shock ⫹ saline
group (two-way RM-ANOVA, F(2,40) ⫽ 23.16, p ⬍ 0.001; multiplecomparisons p ⫽ 0.0004). norBNI treatment before stress reinstatement (24 h earlier) attenuated nicotine’s hypolocomotive effects
during the prime test because there was no significant difference
between this group and saline controls (p ⫽ 0.08; Fig. 1E). These
data suggest that KOR activity is necessary for stress-induced reinstatement, but not prime reinstatement of nicotine CPP, and that the
effect is specific to stress and not prime-induced reinstatement.
KOR activation is necessary for yohimbine-induced
nicotine reinstatement
To determine whether the widely used pharmacological stressor
yohimbine (Lê et al., 2005; Banna et al., 2010; Mantsch et al.,
2010; Mantsch et al., 2016) would also induce nicotine CPP rein-
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Figure 1. KOR activation is necessary for foot-shock stress-induced nicotine reinstatement. A, Timeline of behavioral testing schedule and protocol. B, Representative traces of locomotor behavior
(distance traveled) during each stage of testing (pre, post, extinction, foot shock reinstatement, prime). C, Foot-shock stress before testing (day 8) reinstates nicotine CPP in a norBNI (10 mg/kg,
i.p.)-sensitive manner. D, Locomotor responses are decreased during nicotine treatment (days 2 and 4, P.M. session) compared with saline-treated controls. E, Neither foot-shock stress nor norBNI
pretreatment changes locomotor behavior during reinstatement testing. n ⫽ 12–16 per group, *p ⬍ 0.05.

statement, we injected yohimbine (2 mg/kg, i.p.) 5 min before
reinstatement testing (see Fig. 2A for timeline). Similar to foot
shock, yohimbine reinstated nicotine CPP in a norBNI (10 mg/
kg, i.p.)-sensitive manner (n ⫽ 8 –10 per group, two-way
RM-ANOVA, F(2,26) ⫽ 18.08, p ⬍ 0.0001; Fig. 2B). Consistent
with our foot-shock results and previous reports (Itzhak and
Martin, 1999), nicotine significantly decreased locomotor responses during P.M. conditioning sessions compared with saline
controls (main effect treatment F(2,26) ⫽ 3.97, p ⫽ 0.04; Fig. 2C).
Locomotor responses during preference and reinstatement tests
were unaltered by pretreatment with norBNI (main effect treatment F(2,26) ⫽ 0.13, p ⫽ 0.88; Fig. 2D).
To corroborate our pharmacological studies and determine
whether the DYN/KOR system is necessary for stress-induced
reinstatement and if genetic deletion of KOR or DYN affects
reinstatement, we tested additional groups with of either the
KOR gene (KOR ⫺/⫺) or pre-pro-DYN (DYN ⫺/⫺) knock-out
mice against their littermate controls. In these groups, we found
that KOR and DYN KO mice displayed CPP scores comparable to
WT control groups (no significant differences in CPP scores during postpreference test). However, neither KOR ⫺/⫺ or DYN ⫺/⫺
mice showed reinstatement of nicotine CPP after yohimbine,
whereas a priming injection of nicotine induced reinstatement in
both groups (two-way RM-ANOVA, main effect treatment, n ⫽

5–9 per group, F(2,18) ⫽ 5.08, p ⫽ 0.02; post hoc comparisons only
showed significant differences during reinstatement: KOR ⫺/⫺
compared with WT, p ⫽ 0.02; DYN ⫺/⫺ compared with WT, p ⫽
0.05; Fig. 2E, Table 1). KOR ⫺/⫺ and DYN ⫺/⫺ mice showed
locomotor responses to nicotine during conditioning similar to
WT controls (main effect treatment not significant F(2,18) ⫽ 1.81,
p ⫽ 0.18; Fig. 2F ). Similarly, no significant differences were detected in distance traveled during preference and reinstatement
testing (main effect treatment not significant F(2,18) ⫽ 0.18, p ⫽
0.84; Fig. 2G). Together, these results suggest that, like foot-shock
stress, the DYN/KOR system is engaged by the pharmacological
stressor yohimbine and that both KOR and pre-pro-DYN play a
critical role in the reinstatement of nicotine CPP.
KOR activation is necessary for increased BLA c-fos
expression after nicotine CPP reinstatement
To investigate the regional effects of stress and yohimbine on
neuronal activity, we performed immunohistochemistry (IHC)
to visualize c-fos, the commonly used immediate to early gene
marker of recent cellular activity (Minatohara et al., 2015). To
determine whether yohimbine-induced reinstatement produced
changes in neural activity throughout the brain, we perfused mice
90 min after the reinstatement test (2 h after yohimbine injection)
and used IHC to visualize c-fos expression (Fig. 3A) in regions
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Figure 2. KOR activation is necessary for yohimbine-induced nicotine reinstatement. A, Experimental timeline for behavioral testing and protocols. B, Yohimbine (2 mg/kg, i.p.) 5 min before
testing reinstates nicotine CPP in a norBNI (10 mg/kg, i.p.)-sensitive manner. C, Nicotine decreases locomotor behavior compared with saline controls. D, Locomotor responses are unchanged during
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yohimbine treatment. F, KOR ⫺/⫺ and DYN ⫺/⫺ mice show similar decrease in locomotion after nicotine treatment as seen in WT controls. G, KOR ⫺/⫺ and DYN ⫺/⫺ mice do not differ from WT
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shown previously to be KOR sensitive (Land et al., 2008; Bruchas
et al., 2011; Li et al., 2012; Crowley et al., 2016). We found that the
percentage of c-fos⫹-stained cells in the BLA was significantly
greater in yohimbine-treated mice than in saline controls (Fig.
3B, n ⫽ 5– 6 mice per group, one-way ANOVA, F(2,13) ⫽ 32.87,
p ⬍ 0.0001). However, corresponding to our behavioral results,
mice pretreated with norBNI before yohimbine reinstatement
had significantly fewer c-fos⫹ cells in the BLA compared with
yohimbine/saline-treated mice ( post hoc comparisons all p ⬍
0.01). No changes were seen in the total number of Nissl-stained
cells between any of the groups (F(2,13) ⫽ 0.102, p ⫽ 0.90; Fig. 3C
for representative images). In other brain regions that we visualized, we failed to detect norBNI-sensitive changes that paralleled
our behavioral results (Table 2). The percentage of c-fos⫹ cells in
the central amygdala (CeA) was increased compared with saline
controls after yohimbine-treatment regardless of norBNI pretreatment (n ⫽ 3– 6 mice per group, one-way ANOVA, F(2,12) ⫽
9.39, p ⫽ 0.003). No changes were seen between any groups in the
percentage of c-fos⫹ cells in the BNST (n ⫽ 3–5 mice per group;
one-way ANOVA, F(2,10) ⫽ 3.78, p ⫽ 0.07). The percentage of

DRN c-fos⫹ cells was also increased after yohimbine einstatement (n ⫽ 2– 6 mice per group; one-way ANOVA, F(2,11) ⫽
54.27, p ⫽ 0.001). Post hoc comparisons showed that, although
both yohimbine-treated groups of mice had significantly more
c-fos⫹ cells than saline controls, the increase was significantly greater in mice pretreated with norBNI compared with
yohimbine/saline-treated mice (all p ⬍ 0.05). Together, these
data support the conclusion that c-fos activity in the BLA is altered in a norBNI-sensitive manner after yohimbine einstatement, suggesting that DYN/KOR system is regulating this system
in response to yohimbine exposure. The changes in BLA c-fos
expression that we observed corresponded to the changes that we
saw in behavior, indicating that KOR signaling within the BLA
may be important in mediating this behavior.
DYN/KOR activity within the BLA is required for
stress-induced nicotine CPP reinstatement
To test the hypothesis that functional KOR signaling in the BLA is
required for yohimbine-induced reinstatement, we locally injected the long-lasting KOR antagonist norBNI (Bruchas et al.,
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Table 2. Mean percentage of c-fos ⴙ/Nissl ⴙ-colabeled cells in the BLA, CeA, BNST,
and DRN after yohimbine-induced nicotine CPP reinstatement
Treatment Group
Region
BLA
CeA
BNST
DRN

Saline-only
2.01 (0.66)
0 (0)
0 (0)
6.77 (1.37)

Yohimbine/saline
a

52.45 (4.75)
40.71 (3.36)a
46.33 (7.39)
34.96 (2.89)a

Yohimbine/norBNI
25.53 (7.62)a,b
31.96 (7.58)a
37.05 (14.99)
74.08 (4.50)a,b

Shown are the mean and (SEM) percent of c-fos ⫹ cells in the BLA, central amygdala (CeA), bed nucleus of the stria
terminalis (BNST), and dorsal raphe nucleus (DRN) after yohimbine reinstatement for each group of mice.
a
Significantly different from saline-only group.
b
Significantly different from yohimbine/saline group.

2007; Melief et al., 2011; Al-Hasani et al., 2015) bilaterally into the
BLA before the start of behavioral testing. KOR antagonism in the
BLA (see Fig. 4 A, B for a timeline for injections and behavior)
before behavioral testing prevents yohimbine-induced nicotine
CPP reinstatement without affecting nicotine CPP acquisition or
prime reinstatement (n ⫽ 8 –12 per group, F(2,48) ⫽ 7.61, p ⫽
0.01; post hoc showed only yohimbine reinstatement scores differed significantly between the two groups p ⫽ 0.0007; Fig.
4C,D). Nicotine significantly decreased locomotion during P.M.
conditioning in both groups of mice compared with A.M. locomotor responses (main effect conditioning session F(3,75) ⫽
102.2, p ⬍ 0.0001; post hoc comparisons p ⫽ 0.01 both groups).
However, mice locally injected with norBNI in the BLA showed
significantly less nicotine-induced hypolocomotion during P.M.
conditioning sessions compared with vehicle-treated controls

(main effect of treatment F(1,25) ⫽ 8.18, p ⫽ 0.008; Fig. 4E). No
differences were seen in locomotor behavior during CPP or reinstatement testing (F(1,18) ⫽ 1.89, p ⫽ 0.18; Fig. 4F ).
To test the hypothesis that KOR expression within the BLA is
necessary for stress-induced reinstatement, we used a recently
developed mouse line to delete KORs selectively within certain
cell types or regions (Van’t Veer et al., 2013a) and crossed it with
the Ai9 tdTomato reporter mouse line to generate a new KOR
cKO tdTomato mouse line (Fig. 5 A, B). Colabeling of GFP cells and
TdTomato cells was observed in 80.56% of BLA cells, indicating
that these cells had successful cre recombination and KOR deletion (Fig. 5C). Conditional deletion of BLA KORs in KOR cKO
mice significantly prevented foot-shock stress-induced nicotine
CPP reinstatement (n ⫽ 6 –9 per group, two-way RM-ANOVA,
F(2,26) ⫽ 4.32, p ⫽ 0.024). Post hoc tests confirmed that the only
significant difference between groups was during the reinstatement test, in which KOR cKO mice injected with AAV-cre-GFP
had significantly lower reinstatement scores than AAV-GFPinjected controls ( p ⫽ 0.011; Fig. 5G). No differences in locomotor behavior were seen between groups during conditioning
(F(1,16) ⫽ 0.002, p ⫽ 0.97; Fig. 5H ) or preference/reinstatement
testing (F(1,16) ⫽ 0.95, p ⫽ 0.34; Fig. 5I ). Together, these data
demonstrate that BLA KORs are necessary for yohimbine and
foot-shock stress-induced reinstatement, but not for acquisition
of the initial association or subsequent nicotine-primed reinstatement, indicating that BLA KORs are critical mediators of
stress-induced nicotine reinstatement. In addition, the localized
viral expression shown in Figure 5, E and F, helps to demonstrate
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naling within BLA CaMKII␣ neurons (Fig.
6B,C for injection diagram, confocal imFigure 4. KOR activation in the BLA is required for yohimbine-induced nicotine reinstatement. A, Experimental timeline. norBNI
ages of viral expression and illustrations was injected into the BLA and mice were tested for yohimbine reinstatement 17 d later. B, Diagram of bilateral norBNI injection into
showing spread of viral expression) with the BLA (coordinates: ML ⫾ 2.9, AP ⫺1.8, DV ⫺5). C, Representative heat maps showing activity during yohimbine reinstateCNO 30 min before reinstatement testing, ment of mice bilaterally injected with vehicle (top) and norBNI (bottom). D, Local norBNI in the BLA before behavioral testing
induced reinstatement to nicotine CPP in prevents yohimbine-induced nicotine CPP reinstatement without affecting nicotine place preference acquisition or prime reinDREADD-injected mice compared with statement. E, Nicotine decreases locomotor responses to nicotine to a greater extent in mice injected with vehicle than mice
mice injected with control virus (n ⫽ 9 injected with norBNI locally into the BLA. F, No changes in locomotor activity were seen during post, yohimbine reinstatement, or
hM4D(Gi) mice and n ⫽ 10 mCitrine con- prime testing between groups. n ⫽ 8 –12 per group, *p ⬍ 0.05.
trols, two-way RM-ANOVA, F(1,17) ⫽
BLA is sufficient to induce nicotine reinstatement; and finally
16.09, p ⫽ 0.0009; Fig. 6D). A two-way RM-ANOVA revealed that,
(4) BLA KORs play a key role in mediating stress, but not
although hM4D(Gi) mice were significantly less active during the
prime-induced nicotine CPP reinstatement. These findings
CNO reinstatement test than during the nicotine CPP posttest, loindicate that BLA KORs play a critical role in stress-induced
comotor responses did not differ between hM4D(Gi) and control
nicotine reinstatement by establishing that elevated signaling
mice during the CPP posttest or reinstatement test (F(1,17) ⫽ 12.39,
via Gi-coupled pathways is sufficient to produce this behavior.
p ⫽ 0.003; Fig. 6E) during the test. As a nonbehavioral confirmation
Together, our data suggest that, during stress, KOR inhibitory
of DREADD activation by CNO, we looked at cfos expression after
signaling within the BLA may serve to change behavioral reCNO reinstatement and saw no costaining of cfos and mCitrine in
sponses to environmental stimuli such as those previously
the BLA. However, there was c-fos expressed in the CeA of the same
associated with the rewarding effects of nicotine.
section, confirming that the lack of c-fos in the BLA was due to CNO
Jackson et al. (2013) found that systemic treatment with noractivation of the DREADDs (Fig. 6B). Together, these data suggest
BNI blocks forced swim-stress-induced nicotine CPP reinstatethat inhibition of CaMKII␣ neurons through G␣i activation after
ment. Here, we extend this initial report and now show that the
nicotine conditioning and extinction is sufficient to induce reinDYN/KOR system within the BLA is necessary stress-induced
statement of nicotine CPP and suggest an anatomically specific innicotine reinstatement. We extend the results of Jackson et al.
tracellular mechanism by which stress can lead to reinstatement of
(2013) by showing that two additional stressors (yohimbine and
nicotine preference.
foot shock) reliably reinstate CPP for nicotine in mice. This KOR
Discussion
effect is specific to stress because norBNI did not block nicotineprimed reinstatement in WT mice. In addition, we report that
The principal findings reported here are as follows: (1) both
KOR and DYN KO mice show similar locomotor responses to nicyohimbine and foot-shock stress reliably reinstate nicotine
otine and condition similarly to WT controls, but genetic disruption
seeking-like behavior in a CPP model in mice in a DYN/KORof the KOR or DYN system results in blockade of stress-induced
dependent manner; (2) the role of KOR in reinstatement is
nicotine CPP reinstatement. Although slightly more variable than
specific to stress because nicotine-prime reinstatement was
WT controls, KOR and DYN KO mice still show nicotine-primed
unaffected by either systemic KOR antagonism or global
knock-out of DYN/KOR; (3) activation of G␣i signaling in the
reinstatement. Therefore, the effects of DYN/KOR system disrup-
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response to nicotine during conditioning. I, No changes in activity were seen during any testing stage. n ⫽ 6 –9 per group, *p ⬍ 0.05.

tion are likely not mediated by nonspecific effects on learning or
memory processes, consistent with previous reports for the KOR
system in cocaine reinstatement (Land et al., 2008; Redila and
Chavkin, 2008; Schindler et al., 2010; Bruchas et al., 2011). Rather,

this system is activated during stress and may potentially be increasing the valence of cues previously associated with nicotine.
As a pharmacological stressor, yohimbine has generated considerable discussion and debate. Recently, Chen et al. (2015) found that
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25-26
27
28
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a discrete cue after responding regardless of
whether the cue was paired with a reward.
Our results increase the understanding of
Extinguish Extinction
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Condition
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AM: Saline
the similarities between the mechanisms of
(1 mg/kg)
Test
Test
AM: Saline Test
viral
PM: Saline
Reinstate
PM: Nicotine
injection
yohimbine and stress. For example, if yo(0.5 mg/kg s.c.)
himbine acts by increasing reward-cue valence, then this may also be the mechanism
B
by which stress reinstates drug seeking. PreAAV5-CamKIIa-HA-hM4D(Gi)-IRES-mCitrine
vious reports have in fact suggested that
D
CeA
stress modifies the salience of cues and can
CeA
L M
thus likewise regulate behavioral respondV
ing (Schindler et al., 2010). Our results raise
the possibility that this may also underlie
BLA
our observations here, although this hyBLA
c-fos
pothesis requires further investigation. If
Nissl
Nissl
yohimbine acts by increasing the salience of
hM4D(Gi)-mCitrine
mCitrine
cues rather than inducing a stressful experi-1.70
C -1.46
E
D
ence, our results show that the DYN/KOR
system plays a role in this increased valence
300
0
6000
mCitrine
mCitrin
of cue-associations within the BLA, which in
hM4D(Gi)
hM4D(G
the case of nicotine CPP, leads to reinstate200
0
**
4000
ment. This may provide evidence that the
100
0
role of DYN/KOR in both yohimbine and
foot-shock stress-induced reinstatement of
2000
mCitrine
0
nicotine CPP likely involves an interaction
hM4D(Gi)
with the cholinergic, noradrenergic, and
0
-100
corticotropin-releasing factor (CRF) sysPost CNO
Post CNO
-1.94
-2.06
tems (Kang-Park et al., 2015; Bashiri et al.,
2016), which are critical in nicotine-seeking Figure 6. Chemogenetic activation of G␣i signaling in the BLA is sufficient to induce reinstatement of nicotine CPP. A, Diagram
behaviors (Yamada and Bruijnzeel, 2011; of hM4D(Gi) DREADD viral injections into BLA and subsequent behavioral experiments. B, Diagram of viral injection into the BLA
Picciotto and Mineur, 2014). However, it is (left) and IHC 20⫻ confocal images of hM4D(Gi) DREADD (middle) and control (mCitrine packaged under CaMKII␣ promoter with
still possible that yohimbine and foot-shock no receptor, right) viral expression in the BLA. mCitrine (cyan), c-fos (red), and Nissl (blue). Scale bars, 50 m. C, Diagram with
stress may use different neural circuits to marks that indicate viral spread in mice included in behavioral dataset. D, Activation of hM4D(Gi) DREADDs in the BLA by CNO is
cause nicotine reinstatement. Future studies sufficient to induce nicotine CPP reinstatement. E, No differences in locomotor activity before or after DREADD activation between
that fully characterize relationships among G␣i and controls. n ⫽ 9 –10 per group, *p ⬍ 0.01.
discrete cues and nicotine seeking and selfment. However, this hypothesis requires thorough manipulaadministration behaviors, as well as a complete neural circuit analytions of BLA signaling pathways and behavioral experiments.
sis for DYN/KOR, are needed in future studies to resolve these
Inhibition of excitatory signaling within the BLA through G␣i
outstanding questions.
activation plays a role in the regulation of synaptic plasticity and
We report that KOR activity in the BLA is a key mediator of
LTP induction in the BLA (Li and Rainnie, 2014). In our study,
stress-induced nicotine reinstatement. Furthermore, local antagG␣i DREADD activation was also sufficient to induce nicotine
onism or selective deletion of KORs in the BLA was sufficient to
CPP reinstatement. This is consistent with a recent report showblock stress-induced nicotine CPP reinstatement. Again, this efing that activation of G␣i DREADDs in the BLA reduces stressfect is stress specific because these manipulations did not affect
induced impairments in learning and memory tasks (Rei et al.,
nicotine prime reinstatement. Systemic yohimbine treatment has
2015) and is consistent with a prior report that showed systemic
been shown to increase neuronal activity and extracellular norKOR activation is sufficient to reinstate nicotine CPP (Al-Hasani
epinephrine levels within the BLA (Buffalari and Grace, 2009).
et al., 2013a). However, some studies contradict this result and
Consistent with this previous work, we show increased expresshow
that optogenetic or pharmacological inhibition of BLA
sion of c-fos, a marker of recent cellular activity, in the BLA after
neurons promotes reinstatement to drug seeking and rewardyohimbine-induced reinstatement that was attenuated in mice
related behaviors (Lalumiere, 2014; Sciascia et al., 2015). These
pretreated with norBNI, indicating the necessity of DYN/KOR
studies used optogenetics to inhibit terminals from specific proactivity during reinstatement testing to induce reinstatement.
jections originating in the BLA, including the prelimbic cortex
Together, our results show a potential mechanism by which
and nucleus accumbens core (Britt et al., 2012; Stefanik and Kamodulation of BLA KOR-coupled intracellular signaling caslivas, 2013), and, given the recent evidence for heterogeneity of
cades during stress can result in nicotine CPP reinstatement. A
BLA projection neurons (Namburi et al., 2015; Crowley et al.,
potential explanation for our results is that we may be inducing
2016), helps to explain these differences. It has also been shown
an anxiety-like state similar to that produced by KOR activation
that activation of BLA terminals in the CeA, a projection often
(Bruchas et al., 2009) and stress (Kim et al., 2005). The neural
implicated in reinstatement of drug seeking and CPP (Mantsch et
adaptations that take place within the BLA (and associated ciral., 2016), decrease anxiety-like behaviors, whereas inhibition of
cuits) during stress can change the behavioral response to a
nicotine-associated context, thus inducing nicotine reinstatethis projection has an anxiogenic effect (Tye et al., 2011). In ad-
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dition, a recent report showed that optogenetic activation of BLA
neurons projecting to the BNST decreases anxiety-like behavior,
but that KOR activation blocks this anxiolytic effect and inhibits
BLA glutamate transmission within this projection (Crowley et
al., 2016). Future work may help to establish whether KORs
within this BLA–BNST circuit play a role in nicotine CPP reinstatement. Although we are not yet able to address the issue of cell
type with respect to our pharmacologic and viral manipulations
within the BLA, our results provide a foundation for future studies to build from when looking at the role of BLA KOR circuitry.
Further, our DREADD CaMKII␣ data, as well as the recent report
from Crowley et al. (2016), suggest that excitatory neurons in the
BLA are a likely mediator.
Here, we demonstrate region specific engagement of the
DYN/KOR system within the BLA during stress-induced reinstatement of nicotine preference. These findings suggest that BLA
KORs play a critical role in stress-induced nicotine seeking by
establishing that elevated signaling via Gi-coupled pathways is
sufficient to produce behaviors in mice thought to reflect the
persistence of nicotine addiction in humans. This work may provide novel insights for the development of therapeutic approaches to prevent stress-related nicotine relapse. Future studies
will attempt to further dissect this BLA circuitry to identify celltype specificity of these KOR circuits involved with stressinduced reinstatement of nicotine CPP and where and how
endogenous DYN tone (cell types) is engaged by stress-induced
nicotine interactions. These studies also further support recent
efforts for using KOR antagonists as therapeutics for relapse to
drug seeking.
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Huge V, Rammes G, Beyer A, Zieglgänsberger W, Azad SC (2009) Activation of kappa opioid receptors decreases synaptic transmission and inhibits long-term potentiation in the basolateral amygdala of the mouse. Eur J
Pain 13:124 –129. CrossRef Medline
Itzhak Y, Martin JL (1999) Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine–alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites. Brain
Res 818:204 –211. CrossRef Medline
Jackson KJ, McLaughlin JP, Carroll FI, Damaj MI (2013) Effects of the
kappa opioid receptor antagonist, norbinaltorphimine, on stress and
drug-induced reinstatement of nicotine-conditioned place preference in
mice. Psychopharmacology (Berl) 226:763–768. CrossRef Medline
Janes AC, Pizzagalli DA, Richardt S, Frederick Bde B, Holmes AJ, Sousa J,
Fava M, Evins AE, Kaufman MJ (2010) Neural substrates of attentional
bias for smoking-related cues: an fMRI study. Neuropsychopharmacology 35:2339 –2345. CrossRef Medline
Kang-Park M, Kieffer BL, Roberts AJ, Siggins GR, Moore SD (2015) Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala. J Pharmacol Exp Ther 355:206 –211.
CrossRef Medline
Kim JJ, Koo JW, Lee HJ, Han JS (2005) Amygdalar inactivation blocks
stress-induced impairments in hippocampal long-term potentiation and
spatial memory. J Neurosci 25:1532–1539. CrossRef Medline
Kim T et al. (2013) Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340:211–216. CrossRef Medline
Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG,
Carroll FI, Nestler EJ, Konradi C, Carlezon WA Jr (2011) Kappa opioid
receptor signaling in the basolateral amygdala regulates conditioned fear
and anxiety in rats. Biol Psychiatry 70:425– 433. CrossRef Medline
Koob GF (2009) Brain stress systems in the amygdala and addiction. Brain
Res 1293:61–75. CrossRef Medline
Koob GF (2013) Addiction is a reward deficit and stress surfeit disorder.
Front Psychiatry 4:72. CrossRef Medline
Lalanne L, Ayranci G, Kieffer BL, Lutz PE (2014) The kappa opioid receptor:
from addiction to depression, and back. Front Psychiatry 5:170. CrossRef
Medline
Lalumiere RT (2014) Optogenetic dissection of amygdala functioning.
Front Behav Neurosci 8:107. CrossRef Medline

9948 • J. Neurosci., September 21, 2016 • 36(38):9937–9948
Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C (2008) The
dysphoric component of stress is encoded by activation of the dynorphin
kappa-opioid system. J Neurosci 28:407– 414. CrossRef Medline
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